Meticulous Research®– leading global market research company published a research report titled “Microfluidic Immunoassay Market by Product Type (Lab-on-chip, POC Analyzers, Reagents & Assay), Technology, Application (Cardiac, Troponin, BNP) – Global Forecast to 2025”.

According to this latest publication from Meticulous Research®, the global microfluidic immunoassay market is expected to grow at a CAGR of 12.7% from 2019 to reach $2.01 billion by 2025. The growth of microfluidic immunoassay market is mainly attributed to greater benefits offered by LOC over conventional quantifiable technologies, growing need of POC in low-resource settings, increasing research activities in the field of microfluidic technology, high influx of venture capital funding for the development of LOC-based POC diagnostics, rapid decision making in emergency care, and rising incidence and prevalence of chronic diseases coupled with aging population. In addition, emerging economies and novel technologies such as paper-based microfluidics will further provide significant opportunities for the various stakeholders in this market. However, factors such as lengthy approval time for POC devices and reluctance of healthcare professionals to replace existing diagnostic platforms - are likely to hinder the market growth. On the other hand, selection of suitable substrate material for designing microfluidic chip; difficulty in up-scaling the process for mass production; and product-design and cost related challenges in the developing countries - are recognized as the major hurdles to overcome.

The global microfluidic immunoassay study presents historical market data in terms of values (2017 and 2018), estimated current data (2019), and forecasts for 2025-by product type [lab on chip/ microfluidic diagnostic (microfluidic analyzers, microfluidic cartridges), other quantifiable point of care diagnostics (POC analyzers, reagent and assays)], technology [point of care lab on chip technology (electrochemical LOC POC technology, optical LOCPOC technology), quantitative nonLOC POC technology], application [cardiac biomarker detection (single biomarker assay, multiplexed panel assay), inflammatory biomarker detection, other biomarkers, and emerging biomarkers], and geography. The study also evaluates industry competitors and analyzes the market at regional and country level.

Based on technology, non-LOC POC technologies segment is estimated to command the largest share of the overall microfluidic immunoassay market in 2019. The large share of this segment is attributed to a greater adoption of these technologies - over the years - for wide range of diagnostic applications. However, LOC POC technology market is expected to grow at the fastest CAGR during the forecast period. This is mainly attributed to greater benefits offered by LOC over conventional POC diagnostic methods and growing research activities in this field - supported by private and public funding.

Based on application, the cardiac biomarker detection segment is estimated to hold the largest share of the overall microfluidic immunoassay market in 2019. The large share of the cardiac biomarker detection segment is primarily attributed to high prevalence of cardiovascular diseases, availability of large number of LOC-based products for cardiac biomarkers, and relatively greater adoption of these products among the end-users.

This research report analyzes major geographies and provides comprehensive analysis for North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), Latin America, and Middle East & Africa. North America commanded the largest share of the overall microfluidic immunoassay market, closely followed by the Europe, and Asia Pacific. However, Asia Pacific region is slated to register the highest growth during the forecast period, primarily due to accelerated growth of economies; lower regulatory hurdles; improving healthcare infrastructure; rising accessibility to healthcare services & innovative products; increasing incidence of infectious and non-communicable diseases with aging population; growing income level of middle class population; and continuous investment & focus of key medical device manufacturing giants in emerging Asian markets.

Scope of the Report:

Market by Product Type

Microfluidic Analyzers
Microfluidic Cartridges
POC Analyzers
Reagents and Assays

Market by Technology

Electrochemical LOC POC Technology
Optical POC LOC Technology

Market by Application

Troponin
Brain Natriuretic Peptide (BNP)
Other Cardiac Biomarkers

Market by Geography

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe (RoE)
Latin America
Middle East & Africa
Asia-Pacific (APAC)
Japan
China
India
Rest of Asia-Pacific (RoAPAC)

The key players operating in the global microfluidic immunoassay market are Abaxis, Inc. (a subsidiary of Zoetis Inc.), Nanōmix, Inc., Abbott Laboratories, Koninklijke Philips N.V., Biosurfit SA, Micropoint Bioscience, Inc., Siloam Biosciences, NanoEnTek Inc., OPKO Health, Inc., and Quidel Corporation among others.

Key questions answered in the report-

Which are the high growth market segments in terms of product type, technology, application, and region/countries?
What was the historical market for microfluidic immunoassay across the globe?
What are the market forecasts and estimates for the period 2019–2025?
What are the major drivers, restraints, challenges, and opportunities in the global microfluidic immunoassay market?
Who are the major players in the global microfluidic immunoassay market?
How is the competitive landscape and who are the market leaders in the global microfluidic immunoassay market?
What are the recent developments in the global microfluidic immunoassay market?
What are the different strategies adopted by the major players in the global microfluidic immunoassay market?
What are the geographical trends and high growth regions/ countries?

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Contact us - Meticulous Research ®
Email - [email protected]
Connect with us on LinkedIn
Contact Sales - +1-646-781-8004